I formulated the missing-self hypothesis for natural killer (NK) cell recognition in the autumn of 1981, while writing the last chapter of my doctoral thesis. In 1975, I had joined the Department ...
Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...
Cell proliferation has also been examined through minichromosome maintenance 2, geminin and Ki 67, as well as the gene s100. Other markers involved in cell propagation and metastasis examined to ...